Cardiorenal syndrome (CRS) describes the pathophysiological interactions between the heart and kidneys in which dysfunction of one organ induces or perpetuates dysfunction of the other. The five-subtype CRS classification developed by Ronco et al., published in the Journal of the American College of Cardiology (2008) and subsequently endorsed by Acute Dialysis Quality Initiative (ADQI) consensus statements, provides the foundational clinical framework distinguishing the directionality and temporality of cardio-renal interactions.
ISN (International Society of Nephrology) has contributed to the clinical understanding of CRS through collaborative work with cardiology professional societies and through KDIGO Controversies Conferences addressing acute kidney injury in the context of heart failure and cardiac surgery. Hemodynamic, neurohormonal, and inflammatory pathways mediate the cardiac-kidney interaction, as comprehensively reviewed by Damman & Testani in the European Heart Journal (2015).
Elevated central venous pressure in decompensated heart failure impairs renal venous drainage and reduces filtration pressure independent of cardiac output, as demonstrated in the landmark analysis by Mullens et al. (Journal of the American College of Cardiology, 2009) showing that elevated right atrial pressure was more strongly associated with AKI than reduced cardiac index in advanced heart failure patients.
Diuretic resistance in CRS represents a significant clinical obstacle. The CARRESS-HF trial (Bart et al., New England Journal of Medicine, 2012) compared ultrafiltration to pharmacological diuresis in decompensated heart failure with worsening renal function, finding that stepped pharmacological therapy was superior to ultrafiltration in weight loss preservation of renal function, with important implications for CRS Type 1 management protocols.
The International Society of Nephrology has underscored the importance of multidisciplinary cardionephrology teams for CRS management. The growing subspecialty of cardiorenal medicine, formalized through joint working groups of the American Society of Nephrology, Heart Failure Society of America, and endorsed by ISN as described in a Kidney International editorial (Rangaswami et al., 2021), represents an important structural response to the complex clinical needs of CRS patients.